E-LIB Suche - Ergebnisse für: Kadowaki, Masafumi

1

An observational study of once-weekly carfilzomib in patien..:

Abe, Yu ; Kubonishi, Shiro ; Ri, Masaki...
Future Oncology. 20 (2024) 17 - p. 1191-1205 , 2024

Link: https://doi.org/10.2217/..

2

An observational study of once-weekly carfilzomib in patien..:

Yu Abe ; Shiro Kubonishi ; Masaki Ri...
doi:10.25402/fon.25314382.v1. , 2024

Link: https://doi.org/10.25402..

3

An observational study of once-weekly carfilzomib in patien..:

Yu Abe ; Shiro Kubonishi ; Masaki Ri...
doi:10.25402/fon.25314382.v1. , 2024

Link: https://doi.org/10.25402..

4

Japanese Society of Medical Oncology/Japan Society of Clini..:

Mishima, Saori ; Naito, Yoichi ; Akagi, Kiwamu...
International Journal of Clinical Oncology. 28 (2023) 8 - p. 941-955 , 2023

Link: https://doi.org/10.1007/..

5

Japanese Society of Medical Oncology/Japan Society of Clini..:

Naito, Yoichi ; Mishima, Saori ; Akagi, Kiwamu...
International Journal of Clinical Oncology. 28 (2023) 7 - p. 827-840 , 2023

Link: https://doi.org/10.1007/..

6

Japanese Society of Medical Oncology/Japan Society of Clini..:

Mishima, Saori ; Naito, Yoichi ; Akagi, Kiwamu...
International Journal of Clinical Oncology. 28 (2023) 10 - p. 1237-1258 , 2023

Link: https://doi.org/10.1007/..

7

Japanese Society of Medical Oncology/Japan Society of Clini..:

Mishima, Saori ; Naito, Yoichi ; Akagi, Kiwamu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542286/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Japanese Society of Medical Oncology/Japan Society of Clini..:

Mishima, Saori ; Naito, Yoichi ; Akagi, Kiwamu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390617/. , 2023

Link: http://www.ncbi.nlm.nih...

9

A multicenter non-randomized, uncontrolled single arm trial..:

Suemori, Koichiro ; Saijo, Masayuki ; Yamanaka, Atsushi...
PLOS Neglected Tropical Diseases. 15 (2021) 2 - p. e0009103 , 2021

Link: https://doi.org/10.1371/..

10

Survival rate in the 23 SFTS patients who received favipira..:

Koichiro Suemori (236240) ; Masayuki Saijo (324701) ; Atsushi Yamanaka (340147)...
https://figshare.com/articles/figure/Survival_rate_in_the_23_SFTS_patients_who_received_favipiravir_/14077461. , 2021

Link: https://doi.org/10.1371/..

11

Time until resolution of clinical symptoms and normalizatio..:

Koichiro Suemori (236240) ; Masayuki Saijo (324701) ; Atsushi Yamanaka (340147)...
https://figshare.com/articles/dataset/Time_until_resolution_of_clinical_symptoms_and_normalization_of_laboratory_parameters_in_the_Non-fatal_group_/14077479. , 2021

Link: https://doi.org/10.1371/..

12

Rank classification of clinical symptoms and laboratory fin..:

Koichiro Suemori (236240) ; Masayuki Saijo (324701) ; Atsushi Yamanaka (340147)...
https://figshare.com/articles/journal_contribution/Rank_classification_of_clinical_symptoms_and_laboratory_findings_/14077452. , 2021

Link: https://doi.org/10.1371/..

13

Basic characteristics of the 23 SFTS patients who received ..:

Koichiro Suemori (236240) ; Masayuki Saijo (324701) ; Atsushi Yamanaka (340147)...
https://figshare.com/articles/dataset/Basic_characteristics_of_the_23_SFTS_patients_who_received_favipiravir_/14077470. , 2021

Link: https://doi.org/10.1371/..

14

A multicenter non-randomized, uncontrolled single arm trial..:

Koichiro Suemori ; Masayuki Saijo ; Atsushi Yamanaka...
https://doi.org/10.1371/journal.pntd.0009103. , 2021

Link: https://doi.org/10.1371/..

15

Clinical characteristics of patients on admission:

Koichiro Suemori (236240) ; Masayuki Saijo (324701) ; Atsushi Yamanaka (340147)...
https://figshare.com/articles/journal_contribution/Clinical_characteristics_of_patients_on_admission_/14077455. , 2021

Link: https://doi.org/10.1371/..